Charles Schwab Investment Management Inc Voyager Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 114,452 shares of VYGR stock, worth $905,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,452

Previous 84,737 35.07%

Holding current value

$905,315

Previous $715,000 48.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$7.15 - $10.84 $212,462 - $322,110	29,715 Added 35.07%	114,452 $1.07 Million
Q4 2023 Feb 06, 2024	SELL	$6.28 - $8.81 $21,578 - $30,271	-3,436 Reduced 3.9%	84,737 $715,000
Q3 2023 Nov 08, 2023	BUY	$7.55 - $11.25 $23,540 - $35,077	3,118 Added 3.67%	88,173 $683,000
Q2 2023 Aug 09, 2023	BUY	$6.94 - $13.99 $503,906 - $1.02 Million	72,609 Added 583.39%	85,055 $973,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $10.09 $16,696 - $34,951	-3,464 Reduced 21.77%	12,446 $74,000

Q1 2022 May 13, 2022	BUY	$2.75 - $9.44 $43,752 - $150,190	15,910 New	15,910 $122,000
Q3 2021 Nov 16, 2021	SELL	$2.63 - $4.12 $300,493 - $470,734	-114,256 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $199,454 - $275,389	-50,623 Reduced 30.7%	114,256 $472,000
Q1 2021 May 17, 2021	SELL	$4.61 - $9.04 $23,100 - $45,299	-5,011 Reduced 2.95%	164,879 $777,000
Q4 2020 Feb 16, 2021	BUY	$7.15 - $12.28 $19,040 - $32,701	2,663 Added 1.59%	169,890 $1.22 Million
Q3 2020 Nov 13, 2020	BUY	$10.01 - $13.75 $5,495 - $7,548	549 Added 0.33%	167,227 $1.79 Million
Q2 2020 Aug 14, 2020	SELL	$8.05 - $14.21 $317,363 - $560,215	-39,424 Reduced 19.13%	166,678 $2.1 Million
Q1 2020 May 15, 2020	BUY	$6.8 - $14.66 $10,302 - $22,209	1,515 Added 0.74%	206,102 $1.89 Million
Q4 2019 Feb 07, 2020	BUY	$12.82 - $16.85 $67,933 - $89,288	5,299 Added 2.66%	204,587 $2.85 Million
Q3 2019 Nov 08, 2019	BUY	$16.31 - $28.29 $968,357 - $1.68 Million	59,372 Added 42.43%	199,288 $3.43 Million
Q2 2019 Aug 09, 2019	BUY	$19.18 - $27.88 $280,929 - $408,358	14,647 Added 11.69%	139,916 $3.81 Million
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $90,152 - $221,548	11,269 Added 9.89%	125,269 $2.4 Million
Q4 2018 Feb 14, 2019	SELL	$8.59 - $18.05 $17,068 - $35,865	-1,987 Reduced 1.71%	114,000 $1.07 Million
Q3 2018 Nov 13, 2018	BUY	$17.11 - $21.74 $246,572 - $313,295	14,411 Added 14.19%	115,987 $2.2 Million
Q2 2018 Aug 08, 2018	BUY	$16.76 - $23.92 $248,869 - $355,188	14,849 Added 17.12%	101,576 $1.99 Million
Q1 2018 May 07, 2018	BUY	$16.16 - $31.31 $156,574 - $303,362	9,689 Added 12.58%	86,727 $1.63 Million
Q4 2017 Jan 17, 2018	BUY	$12.26 - $25.88 $334,085 - $705,230	27,250 Added 54.73%	77,038 $1.28 Million
Q3 2017 Nov 13, 2017	BUY	$8.37 - $20.59 $416,725 - $1.03 Million	49,788	49,788 $1.03 Million

Others Institutions Holding VYGR

# of Institutions

134

Shares Held

34.2M

Call Options Held

35.3K

Put Options Held

63K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $306M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Voyager Therapeutics, Inc. Transaction History